Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease.

Atherosclerotic renovascular disease (RVD) reduces renal blood flow (RBF) and GFR and accelerates poststenotic kidney (STK) tissue injury. Preclinical studies indicate that mesenchymal stem cells (MSCs) can stimulate angiogenesis and modify immune function in experimental RVD. We assessed the safety and efficacy of adding intra-arterial autologous adipose-derived MSCs into STK to standardized medical treatment in human subjects without revascularization. The intervention group (n=14) received a single infusion of MSC (1.0 × 105 or 2.5 × 105 cells/kg; n=7 each) plus standardized medical treatment; the medical treatment only group (n=14) included subjects matched for age, kidney function, and stenosis severity. We measured cortical and medullary volumes, perfusion, and RBF using multidetector computed tomography. We assessed tissue oxygenation by blood oxygen level-dependent MRI and GFR by iothalamate clearance. MSC infusions were well tolerated. Three months after infusion, cortical perfusion and RBF rose in the STK (151.8-185.5 ml/min, P=0.01); contralateral kidney RBF increased (212.7-271.8 ml/min, P=0.01); and STK renal hypoxia (percentage of the whole kidney with R2*>30/s) decreased (12.1% [interquartile range, 3.3%-17.8%] to 6.8% [interquartile range, 1.8%-12.9%], P=0.04). No changes in RBF occurred in medical treatment only subjects. Single-kidney GFR remained stable after MSC but fell in the medical treatment only group (-3% versus -24%, P=0.04). This first-in-man dose-escalation study provides evidence of safety of intra-arterial infusion of autologous MSCs in patients with RVD. MSC infusion without main renal artery revascularization associated with increased renal tissue oxygenation and cortical blood flow.

[1]  G. Gomes,et al.  Renovascular hypertension: Effects of mesenchymal stem cells in the contralateral hypertensive kidney in rats , 2016, Clinical and experimental hypertension.

[2]  L. Lerman,et al.  Differences in GFR and Tissue Oxygenation, and Interactions between Stenotic and Contralateral Kidneys in Unilateral Atherosclerotic Renovascular Disease. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[3]  M. Boim,et al.  Mesenchymal stem cells and chronic renal artery stenosis. , 2016, American journal of physiology. Renal physiology.

[4]  S. Textor,et al.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease? , 2015, Physiology.

[5]  Ralph B D'Agostino,et al.  Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.

[6]  L. Lerman,et al.  Human renovascular disease: estimating fractional tissue hypoxia to analyze blood oxygen level-dependent MR. , 2013, Radiology.

[7]  L. Lerman,et al.  Stent Revascularization Restores Cortical Blood Flow and Reverses Tissue Hypoxia in Atherosclerotic Renal Artery Stenosis but Fails to Reverse Inflammatory Pathways or Glomerular Filtration Rate , 2013, Circulation. Cardiovascular interventions.

[8]  Tetsuhiro Tanaka,et al.  Angiogenesis and hypoxia in the kidney , 2013, Nature Reviews Nephrology.

[9]  L. Lerman,et al.  Inflammatory and injury signals released from the post-stenotic human kidney. , 2013, European heart journal.

[10]  L. Lerman,et al.  Mesenchymal Stem Cells and Endothelial Progenitor Cells Decrease Renal Injury in Experimental Swine Renal Artery Stenosis Through Different Mechanisms , 2013, Stem cells.

[11]  S. K. Park,et al.  Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. , 2013, Kidney international.

[12]  A. Rule,et al.  Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  L. Lerman,et al.  Changes in Glomerular Filtration Rate After Renal Revascularization Correlate With Microvascular Hemodynamics and Inflammation in Swine Renal Artery Stenosis , 2012, Circulation. Cardiovascular interventions.

[14]  S. Segerer,et al.  The role of lymphatics in renal inflammation. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  L. Lerman,et al.  Adipose Tissue‐Derived Mesenchymal Stem Cells Improve Revascularization Outcomes to Restore Renal Function in Swine Atherosclerotic Renal Artery Stenosis , 2012, Stem cells.

[16]  A. Dietz,et al.  Platelet Lysate Consisting of a Natural Repair Proteome Supports Human Mesenchymal Stem Cell Proliferation and Chromosomal Stability , 2011, Cell transplantation.

[17]  L. Lerman,et al.  Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling. , 2011, American journal of physiology. Renal physiology.

[18]  R. Lavi,et al.  Early atherosclerosis aggravates the effect of renal artery stenosis on the swine kidney. , 2010, American journal of physiology. Renal physiology.

[19]  L. Lerman,et al.  Endothelial Progenitor Cells Homing and Renal Repair in Experimental Renovascular Disease , 2010, Stem cells.

[20]  K. Reidy,et al.  Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. , 2010, Kidney international.

[21]  D. Buckley,et al.  Effects of renal volume and single-kidney glomerular filtration rate on renal functional outcome in atherosclerotic renal artery stenosis. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  M. Klein.  Revascularization versus Medical Therapy for Renal-Artery Stenosis , 2010 .

[23]  C. Baigent,et al.  Revascularization versus medical therapy for renal-artery stenosis. , 2009, The New England journal of medicine.

[24]  L. Lerman,et al.  Comparison of 1.5 and 3 T BOLD MR to Study Oxygenation of Kidney Cortex and Medulla in Human Renovascular Disease , 2009, Investigative radiology.

[25]  V. Tkachuk,et al.  Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. , 2009, Tissue engineering. Part A.

[26]  T. Murohara,et al.  Implantation of Adipose-Derived Regenerative Cells Enhances Ischemia-Induced Angiogenesis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[27]  J. Norman,et al.  Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. , 2008, Kidney international.

[28]  S. Riederer,et al.  The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. , 2008, Journal of the American Society of Nephrology : JASN.

[29]  K. Alitalo,et al.  Molecular biology and pathology of lymphangiogenesis. , 2008, Annual review of pathology.

[30]  E. Ritman,et al.  Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT. , 2007, Radiology.

[31]  J. Norman,et al.  INTRARENAL OXYGENATION IN CHRONIC RENAL FAILURE , 2006, Clinical and experimental pharmacology & physiology.

[32]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[33]  S. Textor,et al.  Renovascular hypertension and ischemic nephropathy. , 2005, Circulation.

[34]  R. Blantz,et al.  Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II. , 2005, Kidney international.

[35]  W. Welch,et al.  Angiotensin-induced defects in renal oxygenation: role of oxidative stress. , 2005, American journal of physiology. Heart and circulatory physiology.

[36]  E. Ritman,et al.  Cortical Microvascular Remodeling in the Stenotic Kidney: Role of Increased Oxidative Stress , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[37]  L. Lerman,et al.  Comparison of acute and chronic antioxidant interventions in experimental renovascular disease. , 2004, American journal of physiology. Renal physiology.

[38]  C. Napoli,et al.  Mechanisms of Renal Structural Alterations in Combined Hypercholesterolemia and Renal Artery Stenosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[39]  C. Napoli,et al.  Distinct Renal Injury in Early Atherosclerosis and Renovascular Disease , 2002, Circulation.

[40]  I. Roberts,et al.  Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  K. Alitalo,et al.  Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen Vascular Endothelial Growth Factor-C* , 1998, The Journal of Biological Chemistry.

[42]  T. Larson,et al.  GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  R R Edelman,et al.  Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. , 1996, Circulation.

[44]  M. Safar,et al.  Split intrarenal hemodynamics in renovascular hypertension. , 1991, Clinical and investigative medicine. Medecine clinique et experimentale.

[45]  S. Turner,et al.  Renal Vascular Response to Sodium Loading in Sons of Hypertensive Parents , 1991, Hypertension.